Li, Bob T <br/><br/>
HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Mar 2016 
 - 414-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1016/j.jtho.2015.10.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--enzymology<br/>Adenocarcinoma of Lung<br/>Aged<br/>Female<br/>Gene Amplification<br/>Genes, erbB-2<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Lung Neoplasms--enzymology<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Mutation<br/>Receptor, ErbB-2--genetics